Understanding how certain cells change in systemic sclerosis
The Lipofibroblast to Myofibroblast Transition in Systemic Sclerosis
This study is looking at how certain cells change in people with systemic sclerosis, a rare autoimmune disease that can cause lung problems, to find new ways to treat the lung issues that come with it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10950562 on NIH RePORTER |
What this research studies
This research investigates the transition of lipofibroblasts to myofibroblasts in systemic sclerosis, a rare autoimmune disease that can lead to severe lung complications. By studying the mechanisms that drive this cellular change, the research aims to identify new treatment targets for systemic sclerosis-associated interstitial lung disease. The approach involves examining the role of PPARg, a key regulator in this process, and how its regulation affects fibrosis. Patients may benefit from insights that could lead to more effective therapies for their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with systemic sclerosis, particularly those experiencing interstitial lung disease.
Not a fit: Patients with other forms of lung disease unrelated to systemic sclerosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively reverse lung fibrosis in patients with systemic sclerosis.
How similar studies have performed: Previous studies have shown promise in targeting the lipofibroblast to myofibroblast transition, suggesting that this approach could yield significant advancements in treatment.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Young, Arissa C — University of California Los Angeles
- Study coordinator: Young, Arissa C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.